BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2822556)

  • 21. Re-evaluation of drug-interaction with alpha-adrenoceptors in vivo and in vitro using imidazole derivatives.
    Savola JM; Virtanen R; Karjalainen A; Ruskoaho H; Puurunen J; Kärki NT
    Life Sci; 1986 Apr; 38(15):1409-15. PubMed ID: 3007911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.
    Sallés J; Badia A
    Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the alpha-1 and alpha-2 adrenoceptor-mediated effects of a series of dimethoxy-substituted tolazoline derivatives in the cardiovascular system of the pithed rat.
    Ruffolo RR; Messick K
    J Pharmacol Exp Ther; 1985 Jan; 232(1):94-9. PubMed ID: 2981322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that dopamine is acting at alpha-adrenoceptors of the rat vas deferens.
    Miranda HF; Wolstenholme WW; Moreu GM; Cuevas N; Bustamante D
    J Recept Res; 1990; 10(5-6):317-32. PubMed ID: 1964177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral cardiovascular alpha- and beta-adrenergic effects of some hypotensive and bradycardic arylalkyl imidazole derivatives in the rat.
    Savola JM; Puurunen J; Ruskoaho H; Kärki NT
    J Pharm Pharmacol; 1985 Jun; 37(6):410-4. PubMed ID: 2862264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat.
    Badia A; Moron A; Cuffi L; Vila E
    Gen Pharmacol; 1988; 19(3):475-81. PubMed ID: 2843416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Adrenoceptor blocking properties of raubasine in pithed rats.
    Demichel P; Gomond P; Roquebert J
    Br J Pharmacol; 1982 Nov; 77(3):449-54. PubMed ID: 6128043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.
    Sallés J; Badia A
    Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
    Ruffolo RR; Yaden EL
    J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential blocking effects of prazosin and yohimbine on pressor responses to neuronally released and exogenously administered noradrenaline in the pithed rat.
    Kimura T; Suzuki S; Satoh S
    Clin Exp Pharmacol Physiol; 1984; 11(6):589-95. PubMed ID: 6536419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic clonidine treatment produces desensitisation of post- but not presynaptic alpha 2-adrenoceptors.
    Finberg JP; Kopin IJ
    Eur J Pharmacol; 1987 Jun; 138(1):95-100. PubMed ID: 3040429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postsynaptic effects of alpha agonists on adrenoceptors of the reserpinized rat vas deferens.
    Breschi MC; Martinotti E; Ducci M; Fantoni B
    Pharmacol Res Commun; 1987 Jun; 19(6):415-27. PubMed ID: 2889223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pre- and postsynaptic alpha-adrenoceptor blocking effects of E-643 in the isolated vas deferens of the rat.
    Shoji T
    Jpn J Pharmacol; 1981 Jun; 31(3):361-8. PubMed ID: 6118449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An examination of factors influencing adrenergic transmission in the pithed rat, with special reference to noradrenaline uptake mechanisms and post-junctional alpha-adrenoceptors.
    Docherty JR; McGrath JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):101-11. PubMed ID: 6252478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
    Orito K; Kishi M; Imaizumi T; Nakazawa T; Hashimoto A; Mori T; Kambe T
    Br J Pharmacol; 2001 Oct; 134(4):763-70. PubMed ID: 11606316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological studies of imidazoline derivatives. I. A comparison of the effect on pre- and postsynaptic alpha-adrenoceptors in the rat vas deferens.
    Takeuchi K; Akatsuka K; Goto K; Kasuya Y
    J Pharmacobiodyn; 1986 Apr; 9(4):375-84. PubMed ID: 3016232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postsynaptic alpha 2-adrenoceptors mediate pressor responses to 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (M-7).
    Drew GM
    Eur J Pharmacol; 1980 Jul; 65(1):85-7. PubMed ID: 6105083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.